Prostate Cancer International is
for 2011 by Great NonProfits
There is an increasing range of evidence to suggest that men who are on long-term statin therapy (with drugs like simvastatin, atorvastatin/Lipitor, or rosuvastatin/Crestor) are at lower risk for prostate cancer and do better than average in terms of treatment outcome if they are diagnosed with prostate cancer.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: EBRT, external beam radiation therapy, outcome, statin | 6 Comments »
There are few good data on the occurrence of chronic fatigue after first-line treatment of localized prostate cancer.
Filed under: Living with Prostate Cancer, Management | Tagged: chronic, EBRT, external beam radiation therapy, fatigue, radical prostatctomy, RP, Treatment | Leave a Comment »
A newly published report suggests that sexual function does indeed decline after external beam radiation therapy (EBRT) for prostate cancer — but only over the first 2 years post-treatment.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: EBRT, ED, erectile dysfucntion, external beam radiation therapy, sexual function | 2 Comments »
In today’s news reports we comment on three different articles dealing with radiotherapy in first-line treatment for localized prostate cancer: Iodine-125-based brachytherapy without adjuvant hormone therapy or EBRT in younger males Comparative outcomes of brachytherapy patients of 60 and younger and > 60 years of age Radiation toxicities after EBRT in men who have had [...]
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: brachytherapy, disease, EBRT, localized, radiation | Leave a Comment »
A paper in press in the Journal of Urology has suggested that, for patients with intermediate-risk prostate cancer who elect treatment with a combination of standard (low dose) brachytherapy and external beam radiation therapy (EBRT), the addition of hormone therapy adds little in terms of clinical benefit.
Filed under: Management, Treatment | Tagged: ADT, androgen deprivation therapy, brachytherapy, combination radiotherapy, EBRT, external beam radiation therapy | Leave a Comment »
A long-term study from the Mayo Clinic reports a low incidence of complications (other than erectile dysfunction) following salvage radiotherapy for men with prostate cancer recurrence after an initial radical prostatectomy.
Filed under: Management, Treatment | Tagged: EBRT, post-surgery, radiation, salvage | Leave a Comment »
Earlier this year we reported the initial results of a truly randomized Canadian trial of cryotherapy vs. external beam radiation therapy (EBRT) for the treatment of localized prostate cancer. The same group of authors have now reported follow-up data on quality of life.
Filed under: Management, Treatment | Tagged: cryoablation, cryotherapy, EBRT, external beam radiation therapy, randomized, trial | 2 Comments »
In today’s news reports we comment on studies dealing with: PSA level, body mass index, risk, and outcomes External beam radiotherapy in treatment of Japanese patients An endorectal balloon to prevent anal/rectal side effects of radiation? The optimal period of neoadjuvant hormone therapy prior to radiation therapy
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: BMI, body mass index, EBRT, endorectal balloon, external beam radiation, neoadjuvant hormone therapy, obesity, PSA | Leave a Comment »
In today’s news reports you will find items on: Obesity and PSA levels Outcomes after external beam radiation therapy Mitoxantrone + predisone after taxotere failure
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: EBRT, external beam radiation therapy, mitoxantrone, obesity, outcome, prednisone, PSA level | Leave a Comment »
Earlier today we reported data from a series of patients treated by Stock et al. with brachytherapy + external beam radiation therapy (EBRT) + androgen deprivation therapy (ADT). According to a HealthDay report published in Forbes magazine, a second paper appears to endorse the findings of Stock and his colleagues.
Filed under: Management, Risk, Treatment, Uncategorized | Tagged: "high risk", ADT, androgen deprivation therapy, brachytherapy, EBRT, external brea, outcomes, radiation therapy | 1 Comment »
Eight-year outcome data are now available for patients with Gleason score 8-10 prostate cancer treated with brachytherapy, external beam radiotherapy (EBRT), and androgen deprivation therapy (ADT).
Filed under: Management, Treatment | Tagged: ADT, androgen deprivation therapy, brachytherapy, EBRT, external beam radiotherapy, Gleason 8-10 | Leave a Comment »
A recent study has assessed the risk of bleeding as a consequence of radiation therapy for localized prostate cancer in men being treated with anticoagulants .
Filed under: Management, Treatment | Tagged: anticoagulant, bleeding, clopidogrel, EBRT, external beam radiation, risk, warfarin | 2 Comments »
Today’s prostate cancer news report summary includes items dealing with: The epigenetics of prostate cancer and their potential importance Selenium + vitamin E + lycopene (in mice) Gleason 7: 4 + 3 versus 3 + 4 — it’s important Proton beam radiotherapy — a topical review EBRT + low dose, permanent seed brachytherapy
Filed under: Diagnosis, Management, Prevention, Risk, Treatment | Tagged: brachytherapy, EBRT, epigenetics, Gleason 3 + 4 4 + 3, lycopene, PBRT, proton beam, selenium, vitamin E | 2 Comments »
Todays news reports adddress: Surgeon and hospital volume and outcomes to radical prostatectomy Adverse events associated with the use of hypofractionated, dose-escalated, IMRT Quality of sexual function after external beam radiation therapy Percentage of positive biopsy cores and response to first-line hormone therapy
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: biopsy, core, EBRT, external beam radiation therapy, hormone therapy, hospital, hypofractionated, IMRT, radical prostatectomy, sexual function, surgeon, volume | Leave a Comment »
This morning’s news reports address: Prostate cancer risk and obesity (again) Italian experience with HIFU at a median follow-up of about 2 years The prognostic value of a 5-year PSA value <0.2 ng/ml in men treated with brachytherapy (with or without EBRT and/or hormones) Proposed European guidelines on the need to remove the seminal vesicles [...]
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: BMI, brachytherapy, EBRT, HIFU, Italy, obesity, picoplatin, Poniard, seminal vesicles | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site